EPTIS
BAM Logo

Bacterial Genome Detection - Multiplex tests - PCR/NAT for gastrointestinal pathogens (548)

[Bakteriengenom-Nachweis – PCR/NAT Multiplex Nachweisverfahren für Gastrointestinale Pathogene (548)]

EPTIS Ringversuch Nr. 1450745 | Letze Änderung 2026-01-30 | URL: https://www.eptis.bam.de/pts1450745 https://www.eptis.bam.de/pts1450745

Name des Anbieters
Name des Anbieters INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Ansässig in Germany
Sprache(n) German, English
Anmerkungen Mixtures of 0 to 4 of the different pathogens specified in the panel are to be expected in the respective individual samples: Selection of Aeromonas spp., Campylobacter spp., Clostridium difficile (toxinogen), Enterohemorrhagic E. coli (EHEC / STEC), Enterotoxigenic E. coli (ETEC), Enteropathogenic E. coli (EPEC), Enteroaggregative E. coli (EAEC), Escherichia coli O157, Plesiomonas spp., Salmonella spp., Shigella/EIEC, Vibrio spp., Yersinia enterocolitica. In order to take into account the usually very different pathogen coverage of commercially available multiplex PCR/NAT concepts, each of the parameters listed above is certified separately as part of the evaluation. Only results from multiplex PCR/NAT test systems with a precisely specified test/kit designation are accepted. The parallel use of singleplex PCR/NAT detection methods for individual pathogens in the panel is not certified. The relatively broad spectrum of pathogen-specific EQA programmes for bacterial genome detection PCR/NAT is still available for this purpose. The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of four German reference institutions responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results and later download your evaluation documents via https://rv-online.instandev.de. The price on our website apply exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors. Our newest EQA program can also be found on our website: https://www.instand-ev.de/en/instand-eqas/eqa-program/
Klassifizierung
Produktgruppen Human test material
Prüfgebiete Medical analysis
Technische Einzelheiten
Prüfobjekt Prüfeigenschaft Prüfmethode
4 samples of 0.3 mL lyophilized cell suspension, respectively Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for simultaneous qualitative detection of up to four different gastrointestinal pathogens. -
Ringversuchsziele
Zielgruppe des Ringversuchs
Relevante Rechtsvorschriften oder Normen
Weitere Ziele
Teilnehmerzahl 100 - 250
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt)

Akkreditiert durch DAkkS (Germany) auf der Grundlage von ISO/IEC 17043

German Bundesärztekammer (General medical Council)

Die Durchführung des Ringversuchs ist in Auftrag gegeben durch German Bundesärztekammer (General medical Council)
Kosten
Teilnahmegebühr
Regelmässig durchgeführt Ja (2 times per year)
Der Ringversuch wird durchgeführt seit Experience with operation of ILCs since 1968
Kontaktdaten des Anbieters
Anbieter Kontaktperson
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Telefon: +49-211-159213-0
Fax:
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Weiss
Telefon: +49-211-159213430
Fax:
E-Mail: weiss@instand-ev.de weiss@instand-ev.de
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5